The Project ASGARD team is dedicated to advancing patient-centered cardiovascular health and prognosis through research-based, innovative, and cost-effective solutions across healthcare sectors. At WHINN, I will introduce our ASGARD risk score, developed to utilize easily accessible biomarkers for personalized surveillance of patients with aortic valve stenosis.